PTC Therapeutics, Inc. (PTCT)
PTC Therapeutics, Inc. (PTCT) is a healthcare company (biotechnology) based in the United States. The share price is $60.00, down 1.60% on the day, which values the company at $5.01B. Price as of 17 Nov 2026, 17:22 UTC, from Yahoo Finance.
Key facts
- Share price
- $60.00−1.60% today
- Market value
- $5.01B
- Forward P/E
- 18.8×
- Funk Score
- 74/100
- 200-week average
- $49.1622% above
- Sector
- Healthcare
Figures as of . Prices from Yahoo Finance (may be delayed); statements from company filings with the SEC and Yahoo Finance. Estimates, not advice.
PTC Therapeutics, Inc. in more detail
PTCT trades at 18.8× next year's expected earnings, 4.3× sales. It sits 22% above its 200-week average of $49.16.
Over the last five fiscal years PTC Therapeutics, Inc. has compounded revenue 35.4% a year. Its Funk Score is 74 out of 100 (financial strength 4.7, profitability 8.2, growth 9.3, each out of 10).
In its favour: Strong Piotroski score; Operating margin is expanding. Worth checking: Altman Z in the distress zone; Beneish M-score flags the accounts.
1 of the superinvestors tracked here hold PTCT, including Louis Bacon (0.4% of the portfolio).
Superinvestors holding PTCT
1 of the investors tracked here report a position in their latest 13F filing.
- Louis Bacon Moore Capital Management0.38% of portfolio · $13.5M · added · Q3 2026
Health Care companies of similar size
- Cogent BiosciencesCOGT
- GRAILGRAL
- LifeStance Health GroupLFST
- BillionToOneBLLN
- Hims & Hers HealthHIMS
- HaemoneticsHAE
- ErascaERAS
- Concentra Group Holdings ParentCON
- Merit Medical SystemsMMSI
- Edgewise TherapeuticsEWTX
- LivaNovaLIVN
- Ionis PharmaceuticalsIONS
Side by side:PTCT vs HAE (PTC Therapeutics, Inc. vs Haemonetics)PTCT vs ERAS (PTC Therapeutics, Inc. vs Erasca)PTCT vs HIMS (PTC Therapeutics, Inc. vs Hims & Hers Health)PTCT vs CON (PTC Therapeutics, Inc. vs Concentra Group Holdings Parent)PTCT vs BLLN (PTC Therapeutics, Inc. vs BillionToOne)
All health care companies by market valueLargest companies in the United StatesAll stocks A–Z
PTC Therapeutics, Inc. (PTCT): questions and answers
What is PTC Therapeutics, Inc.'s market cap?
PTC Therapeutics, Inc. is valued at $5.01B at a share price of $60.00.
Is PTCT above its 200-week moving average?
Yes. PTCT is 22.0% above its 200-week average of $49.16. Long-term investors watch that line because strong companies rarely trade below it for long.
How fast is PTC Therapeutics, Inc. growing?
Over the last five fiscal years PTC Therapeutics, Inc.'s revenue grew 35.4% a year; over ten years revenue grew 47.0% a year.
Does PTCT pay a dividend?
PTC Therapeutics, Inc. does not currently pay a regular dividend.
Which famous investors own PTCT?
In their latest quarterly filings, Louis Bacon (0.4% of the portfolio) hold PTCT. These filings are published up to 45 days after each quarter ends, so positions may have changed since.
Learn to read these numbers
All stocks guides →- Altman Z-score: formula, zones and where it fails
The Altman Z-score is a weighted sum of five financial ratios that Edward Altman fitted in 1968 to separate companies that went bankrupt from those that did not. Funkfolio reads above 2.99 as the safe zone, below 1.81 as the distress zone, and between them a grey zone. It does not suit banks or insurers.
- Analyst price targets and ratings: what they mean
An analyst price target is a research analyst's estimate of where a share price will be at a set horizon, such as twelve months; a rating such as buy or hold is that analyst's recommendation. A consensus is an average or median of the targets a data provider has collected. Studies have found targets on average well above later prices.
- Free cash flow and FCF yield explained
Free cash flow is the cash a business generates from operations minus what it spends on equipment, buildings and other long-lived assets. Free-cash-flow yield divides that cash by the company's market value: $5 billion of free cash flow on a $100 billion company is a 5% yield. It is cash available to owners and lenders, not profit.
Cite this page
Funkfolio, “PTC Therapeutics, Inc. (PTCT) stock: price, valuation and fundamentals”, data as of 17 November 2026. https://funkfolio.com/stock/PTCT
Underlying data: Yahoo Finance; company filings with the SEC.